Safety of Saffron in Patients with SIBO and Pancreatic Enzyme Deficiency

Evidence for Safety Profile

• The American Gastroenterological Association suggests that SSRIs should not be used specifically for IBS symptoms, but they remain appropriate for treating depression and anxiety in patients with SIBO and pancreatic enzyme deficiency 7, 8, 9
• Saffron does not interfere with pancreatic enzyme replacement therapy, and does not affect fat-soluble vitamin absorption, pancreatic enzyme function, or digestive processes requiring pancreatic enzymes 3
• The combination of saffron with SSRIs has been studied and found safe, with no reported risk of serotonin syndrome, unlike the risk when combining SSRIs with MAOIs or multiple serotonergic drugs 4, 5, 6

Practical Considerations

• Patients with pancreatic insufficiency require pancrelipase replacement with meals to improve digestion and nutrient absorption, and saffron supplementation does not affect this process 3
• The psychiatric benefits of continuing SSRIs outweigh gastrointestinal concerns, as abrupt discontinuation risks withdrawal syndrome and psychiatric decompensation, according to the American Academy of Child and Adolescent Psychiatry 10